257 related articles for article (PubMed ID: 28746356)
1. Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
Kim HH; Jeong IH; Hyun JS; Kong BS; Kim HJ; Park SJ
PLoS One; 2017; 12(7):e0181758. PubMed ID: 28746356
[TBL] [Abstract][Full Text] [Related]
2. A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Gebregiworgis T; Nielsen HH; Massilamany C; Gangaplara A; Reddy J; Illes Z; Powers R
J Proteome Res; 2016 Feb; 15(2):659-66. PubMed ID: 26759122
[TBL] [Abstract][Full Text] [Related]
3. Nontarget metabolomics profiling of neuromyelitis optica spectrum disorder.
Deng J; Xia Z; Qiu D; Jiao X; Xiao B; Zhou W; Yang H; Li J
Biomed Chromatogr; 2019 Jul; 33(7):e4533. PubMed ID: 30891765
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder.
Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Aoki R; Kuwabara S
Clin Exp Immunol; 2020 Nov; 202(2):239-248. PubMed ID: 32643149
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
6. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
Peng L; Bi C; Xia D; Mao L; Qian H
Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
[TBL] [Abstract][Full Text] [Related]
7. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolic profiles and metal levels of patients with multiple sclerosis and patients with neuromyelitis optica spectrum disorders - NMR spectroscopy and ICP-MS studies.
Toczylowska B; Zieminska E; Podlecka-Pietowska A; Ruszczynska A; Chalimoniuk M
Mult Scler Relat Disord; 2022 Apr; 60():103672. PubMed ID: 35240533
[TBL] [Abstract][Full Text] [Related]
9. Choroid plexus changes on magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder.
Kim H; Lim YM; Kim G; Lee EJ; Lee JH; Kim HW; Kim KK
J Neurol Sci; 2020 Aug; 415():116904. PubMed ID: 32446012
[TBL] [Abstract][Full Text] [Related]
10. An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue.
Tackley G; Kong Y; Minne R; Messina S; Winkler A; Cavey A; Everett R; DeLuca GC; Weir A; Craner M; Tracey I; Palace J; Stagg CJ; Emir U
Neuroimage; 2021 Sep; 238():118225. PubMed ID: 34062267
[TBL] [Abstract][Full Text] [Related]
11. Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder.
Combes AJE; Matthews L; Lee JS; Li DKB; Carruthers R; Traboulsee AL; Barker GJ; Palace J; Kolind S
Neuroimage Clin; 2017; 16():17-22. PubMed ID: 28725551
[TBL] [Abstract][Full Text] [Related]
12. Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Moussallieh FM; Elbayed K; Chanson JB; Rudolf G; Piotto M; De Seze J; Namer IJ
Mult Scler; 2014 Apr; 20(5):558-65. PubMed ID: 24080986
[TBL] [Abstract][Full Text] [Related]
13. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
Viswanathan S; Rose N; Arip M; Chai CH; Law WC; Sim R; Ong MC
Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
[TBL] [Abstract][Full Text] [Related]
17. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
[TBL] [Abstract][Full Text] [Related]
18. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
[TBL] [Abstract][Full Text] [Related]
19. Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.
Kimura A; Takemura M; Saito K; Serrero G; Yoshikura N; Hayashi Y; Inuzuka T
J Neuroimmunol; 2017 Apr; 305():175-181. PubMed ID: 28100408
[TBL] [Abstract][Full Text] [Related]
20. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
